Dr Tessa Copp
Dr Tessa Copp (BA Hons, PhD) is an NHMRC Emerging Leader Research Fellow in the University of Sydney School of Public Health. She is part of the Sydney Health Literacy Lab and Wiser Healthcare National Collaboration. Her research focuses on evidence-based healthcare and overdiagnosis, with a particular focus on women’s reproductive health. Her research on polycystic ovary syndrome and the anti-Mullerian hormone test has been published in high impact journals in the field, including The BMJ and Human Reproduction.
2024 ISDM Society Best Oral Presentation Award 1st Place, International Shared Decision-Making Conference, Lausanne, Switzerland
2023 Best ‘Other’ Publication, Wiser Healthcare Publication Award
2022 Best Abstract in category, FMH Networks EMCR Showcase
2021 Best Qualitative Publication, Wiser Healthcare Publication Award
2020 Peter Bancroft Prize for Research Work, Faculty of Medicine and Health
2020 PhD Public Health (Medicine), The University of Sydney, Australia. Thesis: Investigation of the benefits and harms of a polycystic ovary syndrome diagnosis and the potential for overdiagnosis
2017 The Aileen Plant Student Publication Award, Sydney School of Public Health, The University of Sydney
2017 Ho Man Kong and Ho Cheng Fung Ying Memorial Scholarship, Faculty of Medicine, The University of Sydney
2015 Bachelor of Arts (Honours in Psychology), The University of Sydney
Project title | Research student |
---|---|
Evaluation of a virtual fracture clinic to manage patients with simple fractures. | Rowena CHARTERIS |
Delivering a virtual fracture clinic to improve the health journey of patients with simple fractures | Min Jiat TENG |
Publications
Journals
- Copp, T., Thompson, R., Hammarberg, K., Lensen, S., Augustine, L., Doust, J., Peate, M., Cvejic, E., Mol, B., Lieberman, D., McCaffery, K. (2024). Attitudes, knowledge and practice regarding the anti-müllerian hormone test among general practitioners and reproductive specialists: A cross-sectional study. BJOG, 131(8), 1072-1079. [More Information]
- Moss, K., Doust, J., Copp, T., Homer, H., Mishra, G. (2024). Fertility treatment pathways and births for women with and without polycystic ovary syndrome—a retrospective population linked data study. Fertility and Sterility, 121(2), 314-322. [More Information]
- Copp, T., Pickles, K., Smith, J., Hersch, J., Johansson, M., Doust, J., McKinn, S., Sharma, S., Hardiman, L., Nickel, B. (2024). Marketing empowerment: how corporations co-opt feminist narratives to promote non-evidence based health interventions. BMJ, 384, e076710. [More Information]
Magazine / Newspaper Articles
- Fotheringham, P., Dorney, E., Copp, T. (2022). Understanding health literacy in practice. O&G Magazine, Vol. 24 No 2, Winter 2022.
2024
- Copp, T., Thompson, R., Hammarberg, K., Lensen, S., Augustine, L., Doust, J., Peate, M., Cvejic, E., Mol, B., Lieberman, D., McCaffery, K. (2024). Attitudes, knowledge and practice regarding the anti-müllerian hormone test among general practitioners and reproductive specialists: A cross-sectional study. BJOG, 131(8), 1072-1079. [More Information]
- Moss, K., Doust, J., Copp, T., Homer, H., Mishra, G. (2024). Fertility treatment pathways and births for women with and without polycystic ovary syndrome—a retrospective population linked data study. Fertility and Sterility, 121(2), 314-322. [More Information]
- Copp, T., Pickles, K., Smith, J., Hersch, J., Johansson, M., Doust, J., McKinn, S., Sharma, S., Hardiman, L., Nickel, B. (2024). Marketing empowerment: how corporations co-opt feminist narratives to promote non-evidence based health interventions. BMJ, 384, e076710. [More Information]
2023
- Copp, T., Thompson, R., Doust, J., Hammarberg, K., Peate, M., Lensen, S., Cvejic, E., Lieberman, D., Mol, B., McCaffery, K. (2023). Community awareness and use of anti-Müllerian hormone testing in Australia: a population survey of women. Human Reproduction, 38(8), 1571-1577. [More Information]
- Pathirana, T., Wang, Y., Martiny, F., Copp, T., Kumar, R., Mendis, K., Tang, J. (2023). Perspectives from China, India and Sri Lanka on the drivers and potential solutions to overuse and overdiagnosis. BMJ Evidence-Based Medicine, 28(2), 85-88. [More Information]
- Johnson, A., Thompson, R., Nickel, B., Shih, P., Hammarberg, K., Copp, T. (2023). Websites Selling Direct-to-Consumer Anti-Mullerian Hormone Tests. JAMA Network Open, 6(8), e2330192. [More Information]
2022
- Nickel, B., Copp, T., Li, T., Dolan, H., Brennan, M., Verde, A., Vaccaro, L., McCaffery, K., Houssami, N. (2022). A systematic assessment of online international breast density information. Breast, 65, 23-31. [More Information]
- Pickles, K., Copp, T., Meyerowitz-Katz, G., Dodd, R., Bonner, C., Nickel, B., Steffens, M., Seale, H., Cvejic, E., Taba, M., Chau, B., McCaffery, K. (2022). COVID-19 Vaccine Misperceptions in a Community Sample of Adults Aged 18–49 Years in Australia. International Journal of Environmental Research and Public Health, 19(11). [More Information]
- Lee, I., Sansone, S., Irfan, M., Copp, T., Beidas, R., Dokras, A. (2022). Implementation of international guidelines for polycystic ovary syndrome: barriers and facilitators among gynecologists and primary care providers. F & S Reports, 3(2), 94-101. [More Information]
2021
- Copp, T., Nickel, B., Lensen, S., Hammarberg, K., Lieberman, D., Doust, J., Mol, B., McCaffery, K. (2021). Anti-Mullerian hormone (AMH) test information on Australian and New Zealand fertility clinic websites: A content analysis. BMJ Open, 11(7), e046927. [More Information]
- Nickel, B., Copp, T., Brennan, M., Farber, R., McCaffery, K., Houssami, N. (2021). Breast Density Notification: A Systematic Review of the Impact on Primary Care Practitioners. Journal of Women's Health, 30(10), 1457-1468. [More Information]
- Dodd, R., Pickles, K., Nickel, B., Cvejic, E., Ayre, J., Batcup, C., Bonner, C., Copp, T., Cornell, S., Dakin, T., Isautier, J., McCaffery, K. (2021). Concerns and motivations about COVID-19 vaccination. The Lancet Infectious Diseases, 21(2), 161-163. [More Information]
2020
- Hersch, J., Copp, T., Jacklyn, G., Jansen, J., Liefers, G., McCaffery, K., Stiggelbout, A. (2020). Authors’ response. Medical Decision Making, 40(6), 715-717. [More Information]
- Copp, T., Muscat, D., Hersch, J., McCaffery, K., Doust, J., Mol, B., Dokras, A., Jansen, J. (2020). Clinicians' perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study. Human Reproduction, 35(3), 660-668. [More Information]
- McCaffery, K., Dodd, R., Cvejic, E., Ayre, J., Batcup, C., Isautier, J., Copp, T., Bonner, C., Pickles, K., Nickel, B., Dakin, T., Cornell, S., et al (2020). Health literacy and disparities in COVID-19–related knowledge, attitudes, beliefs and behaviours in Australia. Public Health Research and Practice, 30(4), 1-9. [More Information]
2019
- Copp, T., Hersch, J., Muscat, D., McCaffery, K., Doust, J., Dokras, A., Mol, B., Jansen, J. (2019). The benefits and harms of receiving a polycystic ovary syndrome diagnosis: a qualitative study of women's experiences. Human Reproduction Open, 2019 (4), 1-12. [More Information]
2017
- Copp, T., Jansen, J., Doust, J., Mol, B., Dokras, A., McCaffery, K. (2017). Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome? BMJ, 358, 1-10. [More Information]
- Copp, T., McCaffery, K., Azizi, L., Doust, J., Mol, B., Jansen, J. (2017). Influence of the disease label polycystic ovary syndrome' on intention to have an ultrasound and psychosocial outcomes: A randomised online study in young women. Human Reproduction, 32(4), 876-884. [More Information]
- Nickel, B., Barratt, A., Copp, T., Moynihan, R., McCaffery, K. (2017). Words do matter: a systematic review on how different terminology for the same condition influences management preferences. BMJ Open, 7(7), 1-12. [More Information]
Selected Grants
2022
- Qualitative evaluation of an online decision support tool for couples with unexplained infertility, Copp T, Mol B, Hammarberg K, Wang R, National Health and Medical Research Council (NHMRC)/Centres of Research Excellence
- Understanding consumers and hospitals perspectives of Medibank patient reported experience measures (PREMs) data: a qualitative interview study, Nickel B, Copp T, Dodd R, McCaffery K, Medibank Private Ltd/Medibank Health Research Fund
2021
- AHRA Women's Health Research and Translation Network - Tessa Copp, Copp T, Monash University/AHRA WHTRN Early and MidCareer Researcher (EMCR)
Further Grants
2018
- Examination of the impact of the polycystic ovary syndrome (PCOS) label on psychosocial outcomes and decision making. Copp T, Jansen J, Hersch J, McCaffery K, Doust J, Mol B, Dokras A, Lifespan Research Network/Lifespan Seed Grants Program, University of Sydney
In the media
The Health Report. What women need to know about the ‘egg timer’ test. August 3, 2024. https://www.abc.net.au/listen/programs/healthreport/amh-fertility-egg-reserve-test/104161568
The Guardian. Widely advertised hormone test unreliable as fertility prediction tool for women, researchers say. July 29, 2024. https://www.theguardian.com/australia-news/article/2024/jul/29/widely-advertised-hormone-test-unreliable-as-fertility-prediction-tool-researchers-say
Sydney Morning Herald. Are Tampons toxic? Here’s what you need to know. July 19, 2024. https://www.smh.com.au/national/are-tampons-toxic-here-s-what-you-need-to-know-20240718-p5juqr.html
The Guardian. Companies marketing useless health products to women using feminist wellbeing messages. Feb 15, 2024. https://www.theguardian.com/australia-news/2024/feb/15/companies-marketing-useless-health-products-to-women-using-feminist-wellbeing-messages
ABC News. Feminism ‘co-opted’ to market non-evidence-based women’s health interventions like AMH /egg timer’ tests, researchers argue. Feb 18, 2024. https://www.abc.net.au/news/2024-02-18/egg-timer-test-amh-fertility-feminism-women-health/103457322
Elle. ‘Feminist’ health marking is preying on women’s fertility fears. Feb 19, 2024. https://www.elle.com.au/life/health-wellness/home-fertility-tests-reliability-study-29003/
Oprah Daily. Why are so many women testing this fertility hormone? March 26, 2024. https://www.oprahdaily.com/life/health/a60268976/amh-levels-testing-fertility/
ABC News. The 'egg timer test' is being sold as a way for women to decide when to have a baby. But experts say it can be misleading. Published 7th March, 2023. https://www.abc.net.au/news/2023-03-07/egg-timer-test-pregnancy-fertility-results/101878462
The Age. ‘Egg timer’ test of fertility marketed ‘misleadingly’, study finds. Published 8thJuly, 2021. https://www.theage.com.au/national/victoria/egg-timer-test-of-fertility-marketed-misleadingly-study-finds-20210708-p58814.html
ABC Health Report. Is this common hormonal disorder overdiagnosed in Australia? March 9, 2020. https://www.abc.net.au/radionational/programs/healthreport/is-pcos-overdiagnosed-in-australia/12038828
The Conversation. 4 myths about polycystic ovary syndrome – and why they’re wrong. February 27, 2020. https://theconversation.com/4-myths-about-polycystic-ovary-syndrome-and-why-theyre-wrong-131908
The Medical Republic. PCOS diagnosis can have unintended consequences. March 18, 2020. http://medicalrepublic.com.au/pcos-diagnosis-can-have-unintended-consequences/25712/amp
Stat News First Opinion. Overdiagnosis and disease labels: the case of polycystic ovary syndrome. November 1, 2017. https://www.statnews.com/2017/11/01/polycystic-ovary-syndrome-overdiagnosis/
Sydney Morning Herald. Broader definition of polycystic ovary syndrome is harming women: Australian experts. August 15, 2017. https://www.smh.com.au/healthcare/expanded-definition-of-polycystic-ovary-syndrome-is-harming-women-australian-experts-warn-20170815-gxwl32.html